# IBANDRONATE SODIUM
> **ANDA204329** · Abbreviated New Drug Application (Generic) · Sponsor: NANG KUANG PHARM CO · Approved 2021-06-16
## Drug
- **FDA Application Number:** ANDA204329
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** Ibandronate Sodium
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** NANG KUANG PHARM CO
- **First approval:** 2021-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204329)
---
*AI Analytics · CC0 1.0*